Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
IHEvsTMEDETF Comparison
iShares U.S. Pharmaceuticals ETF (IHE) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IHE is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.44% for TMED. IHE is up 4.3% year-to-date (YTD) with +$129M in YTD flows. TMED performs worse with 0.13% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IHE and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IHE vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE TMED | -1.82%+1.16% | +5.93%+1.57% | +4.30%+0.13% | +28.47%n/a | +63.32%n/a | +61.21%n/a |
| Flows | IHE TMED | +$9M+$1M | +$154M+$4M | +$129M+$3M | +$248M- | +$359M- | +$393M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE TMED | +15.86%+16.57% | +20.40%n/a | +15.94%n/a | +15.80%n/a |
| Max drawdown | IHE TMED | -4.49%-7.14% | -14.18%n/a | -16.04%n/a | -16.12%n/a |
| Max drawdown duration | IHE TMED | 10d47d | 150dn/a | 210dn/a | 669dn/a |
IHE | TMED | |
Last sale 3/11/2026 at 1:30 PM | $88.40 | $29.57 |
| Previous close 03/11/2026 | $88.62 | $29.70 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHE | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHE | TMED | |
|---|---|---|
| Last price | $88.40 | $29.57 |
| 1D performance | -0.25% | -0.42% |
| AuM | $1.02 B | $19.32 M |
| E/R | 0.38% | 0.44% |
IHE | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | T. Rowe Price |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | - |
| N° of holdings | 46 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the IHE and TMED ETFs performed in 2026?
As of March 11, 2026, IHE is up 4.3% year-to-date (YTD), while TMED has returned 0.13%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: IHE or TMED?
Year-to-date, the IHE ETF saw +$129M in flows, compared to +$3M for TMED.
Which ETF is bigger: IHE or TMED?
As of March 11, 2026, IHE holds $1.02 B in assets under management (AUM), while TMED manages $19.32 M.
What sectors do the IHE and TMED ETFs invest in?
IHE leans toward sectors like Health Care. Meanwhile, TMED focuses on Health Care.
What are the top holdings of the IHE ETF and TMED ETF?
IHE top holdings include JOHNSON&JOHNSON, LILLY and MERCK & CO INC. TMED holds in its top three: LILLY, UNITEDHEALTH GRP and GILEAD SCIENCES.
Which ETF is more diversified: IHE or TMED?
IHE holds 56 securities with 84.8% of its assets in the top 15. TMED has 80 securities and a top 15 weight of 56.46%.
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
Healthcare Stocks Rebound
Health is Wealth: A look at the Healthcare Sector
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
